Physician Assistant in Holloman Afb, NM Accepting Medicare

7 Physician Assistant nurses found. Showing 1 - 7

Lauren Hudson, PA-S Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 280 David L Goldfein St Bldg 23, Holloman Afb, NM 88330 Phone: 575-572-0149

Matthew Lawrence, Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 280 1st St, Holloman Afb, NM 88330 Phone: 575-572-7091

Paul V Mcglynn Jr., P.A. Physician Assistant Medicare: Medicare Enrolled Practice Location: 49th Medical Group/sgopf, 280 First Street, Bldg 23, Holloman Afb, NM 88330 Phone: 575-572-7091    Fax: 575-572-2259

Janice Perido, PA-C Physician Assistant - Medical Medicare: Not Enrolled in Medicare Practice Location: 280 1st St, Holloman Afb, NM 88330 Phone: 575-572-1859

Mr. Samuel Thomas Schmidt, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 280 1st St Bldg 23, Holloman Afb, NM 88330 Phone: 575-572-3411

Rhiannon Olson, PA Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 280 1st St, Holloman Afb, NM 88330 Phone: 575-572-4908

Angela Lea Barney, PA-C Physician Assistant - Medical Medicare: Accepting Medicare Assignments Practice Location: 280 1st St, Holloman Afb, NM 88330 Phone: 505-572-3041

News Archive

VIVUS disappointed with FDA Advisory Committee's vote on QNEXA for obesity treatment

VIVUS, Inc. today announced that the Endocrinologic and Metabolic Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) voted against the following question: "Based on the current available data, do you believe the overall benefit-risk assessment of PHEN/TPM (QNEXA) is favorable to support its approval for the treatment of obesity in individuals with a BMI > 30 kg/m2 or > 27 kg/m2 with weight-related co-morbidities?" The three co-morbidities included hypertension, diabetes and dyslipidemia.

Obese mothers can make impact on birth weight, diabetes risk of grandchildren: Study

Health problems linked to obesity - like heart disease and diabetes - could skip an entire generation, a new study suggests.

Mirati to present data on tyrosine kinase inhibitor at ESMO 2015 European Cancer Congress

Mirati Therapeutics, Inc., an oncology company focusing on genetic and epigenetic drivers of cancer, today announced it will present data on its tyrosine kinase inhibitor, MGCD516, at the ESMO 2015 European Cancer Congress being held in Vienna, Austria from September 25-29, 2015.

Texas leaders cut spending for Medicaid, Wyo. begins to set up state exchange

"State leaders, trying to dig out of a hole in the current two-year budget before the next one has to be whacked, ordered agencies Tuesday to further curb spending. Agency chiefs were told in a letter that they must reduce expenditures by 2.5% in the remaining nine months of the fiscal year. Managers of the state Medicaid program immediately announced they would cut another 1% from the fees paid to doctors, dentists and hospitals, along with 2% in payments to nursing homes and home health care providers. The decreases take effect Feb. 1, and they come on top of 1% cuts that kicked in just before Labor Day" (Garrett, 12/8).

Renishaw launches unique healthcare facility at Miskin site in South Wales

Global precision engineering company Renishaw plc has announced a new Healthcare Centre of Excellence at its Miskin site, located close to Cardiff, South Wales.

Read more Medical News

› Verified 1 days ago